Sharon M Weber, MD, FACS


  • Chief, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology
Clinic: (608) 263-7502

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375 Clinical Science Center
Madison, Wisconsin 53792-3284


  • MD, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • Pancreatic cyst characterization: maximum axial diameter does not measure up.
    Awe AM, Rendell VR, Lubner MG, Weber S, Winslow ER
    HPB (Oxford) 2020 Dec 11;
    [PubMed ID: 33317934]

  • Low Rate of SARS-CoV-2 Infection in Adults With Active Cancer Diagnosis in a Nonendemic Region in the United States.
    Puckett Y, Wilke L, Weber S, Parkes A, LoConte NK
    WMJ 2020 Dec; 119(4): 286-288
    [PubMed ID: 33428842]

  • A telephone-based surgical transitional care program with improved patient satisfaction scores and fiscal neutrality.
    Schreiter NA, Fisher A, Barrett JR, Acher A, Sell L, Edwards D, Leverson G, Joachim A, Weber SM, Abbott DE
    Surgery 2021 Feb; 169(2): 347-355
    [PubMed ID: 33092810]

  • Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    Aiken TJ, Stahl CC, Schwartz PB, Barrett J, Acher AW, Lemaster D, Leverson G, Weber S, Neuman H, Abbott DE
    J Surg Oncol 2021 Jan; 123(1): 104-109
    [PubMed ID: 32939750]

  • A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.
    Witt JS, Kuczmarska-Haas A, Lubner M, Reeder SB, Cho SY, Minter R, Weber S, Ronnekleiv-Kelly S, Abbott D, LoConte N, Mulkerin DL, Lubner SJ, Uboha NV, Deming D, Ritter MA, Mohindra P, Bassetti MF
    Int J Radiat Oncol Biol Phys 2021 Feb 01; 109(2): 458-463
    [PubMed ID: 32942002]

All Publications on PubMed